165 related articles for article (PubMed ID: 9189179)
1. The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifen.
Bezwoda WR
Cancer Treat Rev; 1997 Jan; 23(1):17-34. PubMed ID: 9189179
[TBL] [Abstract][Full Text] [Related]
2. The treatment of metastatic melanoma with chemotherapy and biologics.
Atkins MB
Curr Opin Oncol; 1997 Mar; 9(2):205-13. PubMed ID: 9161801
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy in melanoma.
Nathan FE; Mastrangelo MJ
Semin Surg Oncol; 1998 Jun; 14(4):319-27. PubMed ID: 9588725
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for advanced malignant melanoma.
Buzaid AC; Murren J
Int J Clin Lab Res; 1992; 21(3):205-9. PubMed ID: 1591369
[TBL] [Abstract][Full Text] [Related]
5. Current therapy for malignant melanoma.
Legha SS
Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
Garbe C
Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of malignant melanoma (author's transl)].
Schmidt CG
Langenbecks Arch Chir; 1976 Nov; 342():539-43. PubMed ID: 994671
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of malignant melanoma].
Avril MF
Ann Dermatol Venereol; 1988; 115(9):959-68. PubMed ID: 2464963
[No Abstract] [Full Text] [Related]
9. Chemotherapy of malignant melanoma.
Luce JK
Cancer; 1972 Dec; 30(6):1604-15. PubMed ID: 4565819
[No Abstract] [Full Text] [Related]
10. Systemic chemotherapy for metastatic melanoma.
Mc Clay EF; Mastrangelo MJ
Semin Oncol; 1988 Dec; 15(6):569-77. PubMed ID: 2462747
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of metastasized malignant melanoma].
Kamanabrou D
Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of melanoma.
Luce JK
Semin Oncol; 1975 Jun; 2(2):179-85. PubMed ID: 1234375
[No Abstract] [Full Text] [Related]
13. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
Tan EH; Ang PT
Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
[TBL] [Abstract][Full Text] [Related]
14. Systemic chemotherapy in the treatment of malignant melanoma.
Lens MB; Eisen TG
Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy for disseminated malignant melanoma.
Abbott KL; Harman GS
Anticancer Drugs; 1995 Aug; 6(4):489-97. PubMed ID: 7579552
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.
Dillman RO; Soori G; Wiemann MC; Schulof R; Dobbs TW; Ruben RH; DePriest CB; Church C
Cancer Biother Radiopharm; 2000 Oct; 15(5):487-94. PubMed ID: 11155820
[TBL] [Abstract][Full Text] [Related]
17. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
18. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
Huncharek M; Caubet JF; McGarry R
Melanoma Res; 2001 Feb; 11(1):75-81. PubMed ID: 11254118
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
[TBL] [Abstract][Full Text] [Related]
20. [New antineoplastic agents, their value and use].
Pawlicki M; Zuchowska-Vogelgesang B
Przegl Lek; 1982 Sep; 39(8):561-5. PubMed ID: 6182581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
